We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Non-Invasive Blood Assay Can Detect Early Colorectal Cancer

By LabMedica International staff writers
Posted on 21 May 2020
Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). More...
In general, colon cancer begins when healthy cells in the colon develop changes (mutations) in their DNA and as the cells accumulate, they form a tumor.

Doctors recommend certain screening tests for healthy people with no signs or symptoms in order to look for signs of colon cancer or noncancerous colon polyps. Finding colon cancer at its earliest stage provides the greatest chance for a cure and screening has been shown to reduce the risk of dying of colon cancer.

Medical Scientist at the Stanford University Medical Center (Stanford, CA, USA) evaluated a novel blood-based assay in a single-center, blinded study conducted at the Veterans Affairs Palo Alto Health Care System (Livermore, CA, USA). The study included 354 patients with no prior CRC diagnosis who were scheduled for colonoscopy. Among these patients, 86% were asymptomatic and 14% had symptoms or a positive fecal immunochemical test.

Prior to colonoscopy, investigators drew blood samples to be analyzed by the test FirstSightCRC (CellMax Life, Sunnyvale, CA, USA), a test that focuses on three biomarkers, circulating gastrointestinal epithelial cells, somatic mutations and methylation of cell-free DNA. The scientists developed a quantitative age- and sex- adjusted composite CMx Score from 0 to 100.

The scientists in their analysis determined that the test achieved a specificity of 90% and sensitivity of 100% and 76% for the detection of CRC and advanced adenomas, respectively. They also found an association between the CMx Score and disease severity. The score also correlated with the size of the index adenomas.

The study included several patients who had elevated CMx Scores but had negative colonoscopies. After reviewing patient histories, the investigators found a prior history of advanced adenoma removal in most cases. This knowledge revealed the potential to achieve an even higher specificity with the test.

Shai Friedland, MD, a professor of medicine and the senior study author, said, “The blood test has the potential to fill an unmet need by giving patients a highly sensitive, convenient option for colorectal cancer screening. We have continued to enroll patients at the Palo Alto VA to prospectively validate the blood test. The results will be available soon, and I can tell you they look extremely promising.” The study was presented at the virtual meeting held May 2-5, 2020 of the Digestive Disease Week.

Related Links:
Stanford University Medical Center
Veterans Affairs Palo Alto Health Care System
CellMax Life



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.